Cartilage Injury of the Knee

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2015-08-31
Clinical Trial Update: A Multicenter Trial of Sprifermin (AS902330 [Recombinant Human Fibroblast Growth Factor-18]) or Placebo After Microfracture Surgery for Cartilage Injury of the Knee [Phase 2]
A multicenter Phase 2 trial evaluating Sprifermin (recombinant human fibroblast growth factor-18) versus placebo after microfracture surgery…